Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis
Lorenz Balcar(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Martin Wagner(Medical University of Graz), Benjamin Maasoumy(Medizinische Hochschule Hannover), Mònica Pons(Universitat Autònoma de Barcelona), Jef Verbeek(KU Leuven), Jan Stolk(Leiden University Medical Center), Lukas Van Melkebeke(KU Leuven), Tammo Lambert Tergast(Medizinische Hochschule Hannover), Georg Semmler(University of Southern Denmark), Markus Peck‐Radosavljevic(Klinikum Klagenfurt), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Jan Šperl(Institute of Clinical and Experimental Medicine), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Bart van Hoek(Leiden University Medical Center), Soňa Fraňková(Institute of Clinical and Experimental Medicine), Naomi Kappe(Erasmus MC), Benedikt Schaefer(Universität Innsbruck), Harald Hofer(Klinikum Wels-Grieskirchen), Anna Sophie Karl(RWTH Aachen University), Heinz Zoller(Innsbruck Medical University), Hannah Rieland(Medizinische Hochschule Hannover), Malin Fromme
Cited by 2
Related Papers
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k